+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Acetylcholine"

Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
Lewy Body Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Lewy Body Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • May 2024
  • 60 Pages
  • Global
From
Spasticity - Pipeline Insight, 2024 - Product Thumbnail Image

Spasticity - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 106 Pages
  • Global
From
Parkinson's disease - Pipeline Insight, 2024 - Product Thumbnail Image

Parkinson's disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Postherpetic Neuralgia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Postherpetic Neuralgia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • April 2024
  • 142 Pages
  • Global
From
Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • April 2024
  • 287 Pages
  • Global
From
Generalized Myasthenia Gravis (gMG) - Pipeline Insight, 2024 - Product Thumbnail Image

Generalized Myasthenia Gravis (gMG) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Dystonia - Pipeline Insight, 2024 - Product Thumbnail Image

Dystonia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Dementia with Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia with Diabetes - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Spasmodic-torticollis - Pipeline Insight, 2024 - Product Thumbnail Image

Spasmodic-torticollis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Lewy Boy Dementia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Lewy Boy Dementia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • June 2024
  • 180 Pages
  • Global
From
North America Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User - Product Thumbnail Image

North America Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User

  • Report
  • September 2024
  • 77 Pages
  • North America
From
Overactive Bladder Treatment (OAB) Market by Drug type ( Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) and Region - Global Forecasts to 2027 - Product Thumbnail Image

Overactive Bladder Treatment (OAB) Market by Drug type ( Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) and Region - Global Forecasts to 2027

  • Report
  • July 2022
  • 203 Pages
  • Global
From
South & Central America Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User - Product Thumbnail Image

South & Central America Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User

  • Report
  • September 2024
  • 66 Pages
From
WAKIX (Pitolisant), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

WAKIX (Pitolisant), Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Cervical Dystonia Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Cervical Dystonia Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 150 Pages
  • Global
From
Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 80 Pages
  • Global
From
Muscarinic Acetylcholine Receptor (mAChR) Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor (mAChR) Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Acetylcholine market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Acetylcholine is a neurotransmitter that plays a role in muscle contraction, memory, and learning. It is used to treat conditions such as Alzheimer's disease, Parkinson's disease, and myasthenia gravis. Acetylcholine is available in both oral and injectable forms, and is often used in combination with other drugs. The Acetylcholine market is highly competitive, with many companies offering products. Some of the major players in the market include Pfizer, Novartis, Merck, GlaxoSmithKline, and Sanofi. Other companies include Allergan, Teva Pharmaceuticals, and Mylan. Show Less Read more